CGRP - The Next Frontier for Migraine
- PMID: 29171812
- DOI: 10.1056/NEJMe1712559
CGRP - The Next Frontier for Migraine
Comment on
-
Fremanezumab for the Preventive Treatment of Chronic Migraine.N Engl J Med. 2017 Nov 30;377(22):2113-2122. doi: 10.1056/NEJMoa1709038. N Engl J Med. 2017. PMID: 29171818 Clinical Trial.
-
A Controlled Trial of Erenumab for Episodic Migraine.N Engl J Med. 2017 Nov 30;377(22):2123-2132. doi: 10.1056/NEJMoa1705848. N Engl J Med. 2017. PMID: 29171821 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials